R Michael Carruthers - Net Worth and Insider Trading
R Michael Carruthers Net Worth
The estimated net worth of R Michael Carruthers is at least $594,593 dollars as of 2024-12-27. R Michael Carruthers is the Exec Vice President / CFO of Alpine Immune Sciences Inc and owns about 6,000 shares of Alpine Immune Sciences Inc (ALPN) stock worth over $389,820. R Michael Carruthers is also the CFO of Edgewise Therapeutics Inc and owns about 6,904 shares of Edgewise Therapeutics Inc (EWTX) stock worth over $204,773. Details can be seen in R Michael Carruthers's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that R Michael Carruthers has not made any transactions after 2024-09-20 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of R Michael Carruthers
R Michael Carruthers Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, R Michael Carruthers owns 4 companies in total, including Fresh Tracks Therapeutics Inc (FRTX) , Alpine Immune Sciences Inc (ALPN) , and Edgewise Therapeutics Inc (EWTX) among others .
Click here to see the complete history of R Michael Carruthers’s form 4 insider trades.
Insider Ownership Summary of R Michael Carruthers
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| FRTX | Fresh Tracks Therapeutics Inc | 2019-08-31 | Chief Financial Officer |
| ALPN | Alpine Immune Sciences Inc | 2016-12-02 | Chief Financial Officer |
| EWTX | Edgewise Therapeutics Inc | 2024-09-20 | Chief Financial Officer |
 | | 2021-06-24 | director |
R Michael Carruthers Latest Holdings Summary
R Michael Carruthers currently owns a total of 2 stocks. Among these stocks, R Michael Carruthers owns 6,000 shares of Alpine Immune Sciences Inc (ALPN) as of December 2, 2016, with a value of $389,820 and a weighting of 65.56%. R Michael Carruthers also owns 6,904 shares of Edgewise Therapeutics Inc (EWTX) as of September 20, 2024, with a value of $204,773 and a weighting of 34.44%.
Latest Holdings of R Michael Carruthers
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ALPN | Alpine Immune Sciences Inc | 2016-12-02 | 6,000 | 64.97 | 389,820 |
| EWTX | Edgewise Therapeutics Inc | 2024-09-20 | 6,904 | 29.66 | 204,773 |
Holding Weightings of R Michael Carruthers
R Michael Carruthers Form 4 Trading Tracker
According to the SEC Form 4 filings, R Michael Carruthers has made a total of 0 transactions in Alpine Immune Sciences Inc (ALPN) over the past 5 years. The most-recent trade in Alpine Immune Sciences Inc is the acquisition of 6,000 shares on December 2, 2016, which cost R Michael Carruthers around $50,160.
According to the SEC Form 4 filings, R Michael Carruthers has made a total of 4 transactions in Edgewise Therapeutics Inc (EWTX) over the past 5 years, including 0 buys and 4 sells. The most-recent trade in Edgewise Therapeutics Inc is the sale of 125,092 shares on September 20, 2024, which brought R Michael Carruthers around $4 Million.
Insider Trading History of R Michael Carruthers
- 1
R Michael Carruthers Trading Performance
GuruFocus tracks the stock performance after each of R Michael Carruthers's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by R Michael Carruthers is 32.85%. GuruFocus also compares R Michael Carruthers's trading performance to market benchmark return within the same time period. The performance of stocks bought by R Michael Carruthers within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how R Michael Carruthers's insider trading performs compared to the benchmark.
Performance of R Michael Carruthers
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 8.21 | | | | | |
| Relative Return to S&P 500(%) | 6.07 | | | | | |
R Michael Carruthers Ownership Network
R Michael Carruthers Owned Company Details
What does Fresh Tracks Therapeutics Inc do?
Who are the key executives at Fresh Tracks Therapeutics Inc?
R Michael Carruthers is the Chief Financial Officer of Fresh Tracks Therapeutics Inc. Other key executives at Fresh Tracks Therapeutics Inc include Chief Medical Officer Monica E. Luchi , director & CHAIRMAN OF THE BOARD Reginald L Hardy , and General Counsel and CCO David R. Mcavoy .
Fresh Tracks Therapeutics Inc (FRTX) Insider Trades Summary
Over the past 18 months, R Michael Carruthers made no insider transaction in Fresh Tracks Therapeutics Inc (FRTX). Other recent insider transactions involving Fresh Tracks Therapeutics Inc (FRTX) include a net sale of 110 shares made by ,
In summary, during the past 3 months, insiders sold 0 shares of Fresh Tracks Therapeutics Inc (FRTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 110 shares of Fresh Tracks Therapeutics Inc (FRTX) were sold and 1,086,412 shares were bought by its insiders, resulting in a net purchase of 1,086,302 shares.
Fresh Tracks Therapeutics Inc (FRTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Fresh Tracks Therapeutics Inc Insider Transactions
R Michael Carruthers Mailing Address
Above is the net worth, insider trading, and ownership report for R Michael Carruthers. You might contact R Michael Carruthers via mailing address: 3122 Sterling Circle, Suite 200, Boulder Co 80301.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
